Psoter Walter J, Kerr Alexander Ross, Tomar Scott L, Psoter Jodi A, Morse Douglas E, Aguilar Maria L, Kligman Kenneth D, Minyé Helena M, Burton Vanessa A, Meyerowitz Cyril
Quintessence Int. 2024 Sep 27;55(8):652-659. doi: 10.3290/j.qi.b5733611.
Oral cancer examinations seek to clinically identify early oral cancers and discover premalignancies prior to their progression to invasive cancer.
A cross-sectional study was conducted between April and August 2017 to explore and quantify the diagnostic approach used by United States (US) general dental practitioners following discovery of an oral lesion suspicious for malignancy/premalignancy. US licensed general dental practitioners who were clinically active members of the US National Dental Practice-Based Research Network were eligible to participate. Data for analysis were obtained via two questionnaires.
The majority of participants were males, practiced full-time, had a suburban primary practice, were born during the 1950s, and graduated dental school in the 1980s or 2000s. After identifying an oral lesion suspicious for premalignancy/malignancy, the next action of most general dental practitioner respondents (65.4%) was to refer the patient for consultation/biopsy. Most general dental practitioners (87.2%) referred to an oral and maxillofacial surgeon; 22% of general dental practitioners reported personally biopsying suspicious lesions. There was a relatively weak association between completing an Advanced Education in General Dentistry or General Practice Residency and subsequently personally performing biopsies on patients with oral lesions suspicious for malignancy/premalignancy (OR 1.33, P = .06). Most written referrals took place electronically and often included information, including lesion location (87.0%), lesion sign/symptoms (85.3%), lesion history (83.9%), radiographs (59.3%), medical history (50.6%), dental history (48.8%), and photographs (42.4%). When a referral biopsy was performed, referring clinicians were most frequently informed of the findings via a written report (96.7%, when positive for malignancy/premalignancy, and 95.4% when negative).
A snapshot is presented of current actions taken by US general dental practitioners following the discovery of oral abnormalities suspicious for premalignancy/malignancy.
口腔癌检查旨在通过临床手段识别早期口腔癌,并在癌前病变发展为浸润性癌之前将其发现。
2017年4月至8月进行了一项横断面研究,以探索和量化美国全科牙医在发现可疑为恶性/癌前病变的口腔病变后所采用的诊断方法。符合条件参与研究的是美国国家基于牙科实践的研究网络中临床活跃的持牌全科牙医。分析数据通过两份问卷获得。
大多数参与者为男性,全职执业,在郊区开设诊所,出生于20世纪50年代,于20世纪80年代或21世纪毕业于牙科学院。在识别出可疑为癌前病变/恶性病变的口腔病变后,大多数全科牙医受访者(65.4%)的下一步行动是将患者转诊进行咨询/活检。大多数全科牙医(87.2%)转诊给口腔颌面外科医生;22%的全科牙医报告亲自对可疑病变进行活检。在完成普通牙科高级教育或全科实习与随后亲自对可疑为恶性/癌前病变的口腔病变患者进行活检之间存在相对较弱的关联(比值比1.33,P = 0.06)。大多数书面转诊通过电子方式进行,且通常包含病变位置(87.0%)、病变体征/症状(85.3%)、病变病史(83.9%)、X光片(59.3%)、病史(50.6%)、牙科病史(48.8%)和照片(42.4%)等信息。当进行转诊活检时,转诊医生最常通过书面报告得知检查结果(恶性/癌前病变呈阳性时为96.7%,阴性时为95.4%)。
呈现了美国全科牙医在发现可疑为癌前病变/恶性病变的口腔异常后当前所采取行动的概况。